ERBB2 and obesity due to melanocortin 4 receptor deficiency: A pooled analysis on the Breast Cancer Association Consortium revealed that among women <50 years of age, obesity was associated more frequently with hormone negative BC than with hormone positive tumors and, by including human epidermal growth factor receptor 2 (HER2) receptors, obesity was confined to TNBC [29].